25.05.2010 • NewsOilPricingSABIC

SABIC Chief: Oil Price Below $65/Barrel a 'Disadvantage'

SABIC Chief Executive Mohamed al-Mady
SABIC Chief Executive Mohamed al-Mady

An oil price of $65 per barrel is still reasonable for all producers, but a price below that level will be a "disadvantage," the chief executive of Saudi Basic Industries Corporation (SABIC) said on Sunday.

"Of course $65 is still reasonable for all producers. If it continued to be much lower, it will be to our disadvantage," Chief Executive Mohamed al-Mady said at an industry event in Bahrain.

He said he was referring to "Middle East countries vs. developed countries and to the petrochemical industry in general."

OPEC's reference crude oil basket price fell further to $69.64 a barrel on Thursday from $70.57 the previous day, OPEC said on Friday. The reference basket comprises 12 crudes.

Mady also said he expected to see 2% growth in petrochemical demand this year in Europe.

"The U.S. economy is very strong, China still, India, the Middle East. Europe is a little bit affected by the financial crisis, but still it has a modest growth and it is continuing to grow. We talk about 2% growth in 2010," Mady said, adding he was referring to petrochemicals demand.

"Demand is still holding because the U.S. and China are sustaining the demand," he said. "In China, I've talked to a lot of Chinese and they have not confirmed they were going to lower demand."

Company

Sabic Europe

Europaboulevard 1
6135 LD Sittard
Netherlands

Company contact







CHEManager Spotlight

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics
Creating Interfaces

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics

CHEManager Spotlight is an exclusive event tailored for practitioners and decision-makers in the chemical industry. This part of our event series delves into the latest trends and innovations in logistics to streamline your operations and drive efficiency.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.